Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.47
-0.27 (-3.49%)
May 18, 2026, 4:00 PM EDT - Market closed

Aura Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
84.7959.5231.6941.06121.58149.06
Short-Term Investments
29.9484.73119.4185.0967.23-
Cash & Short-Term Investments
114.73144.24151.09226.15188.81149.06
Cash Growth
-10.36%-4.54%-33.19%19.78%26.66%757.03%
Other Current Assets
3.775.59.535.647.894.64
Total Current Assets
118.5149.74160.62231.79196.7153.7
Net Property, Plant & Equipment
17.8918.4520.592226.046.2
Other Long-Term Assets
1.291.241.291.281.190.13
Total Assets
137.68169.43182.5255.08223.94160.03
Accounts Payable
2.571.552.31.792.922.4
Accrued Expenses
10.8713.599.467.884.574.34
Current Portion of Leases
3.273.243.152.692.960.62
Total Current Liabilities
16.7118.3814.9112.3610.467.36
Long-Term Leases
13.7214.1315.6216.8717.90.36
Total Long-Term Liabilities
13.7214.1315.6216.8717.90.36
Total Liabilities
30.4332.5230.5329.2328.357.72
Additional Paid-in Capital
621.56617.43525.93512.62406.56304.45
Accumulated Other Comprehensive Income
-0.21-0.10.260.54-0.07-
Retained Earnings
-514.1-480.42-374.23-287.31-210.9-152.14
Total Common Shareholders' Equity
107.25136.91151.97225.85195.58152.32
Shareholders' Equity
107.25136.91151.97225.85195.58152.32
Total Liabilities & Equity
137.68169.43182.5255.08223.94160.03
Total Debt
16.9917.3818.7719.5620.860.98
Net Cash (Debt)
97.74126.86132.33206.59167.95148.09
Net Cash Growth
-22.96%-4.13%-35.95%23.01%13.41%751.42%
Net Cash Per Share
1.512.102.675.215.6128.70
Book Value
107.25136.91151.97225.85195.58152.32
Book Value Per Share
1.662.273.065.706.5329.52
Tangible Book Value
107.25136.91151.97225.85195.58152.32
Tangible Book Value Per Share
1.662.273.065.706.5329.52
Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q